Policy Position Statements
WBBA Opposes Initiative 522
The Washington Biotechnology & Biomedical Association (WBBA) opposes I-522. To require the labeling of foods that are indistinguishable from foods produced through traditional methods would mislesd consumers by falsely implying differences where none exist. WBBA opposes mandatory labeling policies and supports current laws and regulations administerd by the FDA and USDA. Please click here to read a more in-depth statement of WBBA's position on Initiative 522.